Lilly’s Symbyax Requires Prior Authorization Under Massachusetts Medicaid
Executive Summary
Massachusetts Medicaid's MassHealth program is requiring prior authorization for Lilly's antipsychotic/ antidepressant combination agent, Symbyax
You may also be interested in...
Ribavirin ANDAs Clear FDA; Schering Goes Generic Too
Three Rivers/Par, Sandoz and Schering-Plough are launching their ribavirin generics at a 10% discount to Schering's Rebetol
Mylan Loses Duragesic Case; Generic Launch Timing Dispute Moves To FDA
The launch timing for the first generic version of Johnson & Johnson/Alza's Duragesic fentanyl patch will depend on FDA's decision about a six-month pediatric exclusivity extension for the product
OxyContin Generics From Endo And Teva Will Include Risk Management Plans
Risk management programs for Endo's and Teva's generic versions of OxyContin reflect differences in the nature of generic marketing compared to that for branded drugs